Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.53 USD | -4.08% | -12.19% | +557.36% |
May. 31 | Piper Sandler Starts Elevation Oncology With Overweight Rating, $10 Price Target | MT |
May. 14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 193M |
---|---|---|---|---|---|
Net income 2024 * | -48M | Net income 2025 * | -62M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.81
x | P/E ratio 2025 * |
-3.61
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.73% |
1 day | -4.08% | ||
1 week | -12.19% | ||
Current month | -12.19% | ||
1 month | +1.44% | ||
3 months | -21.56% | ||
6 months | +514.98% | ||
Current year | +557.36% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Ferra
CEO | Chief Executive Officer | 48 | 21-06-16 |
Tammy Furlong
DFI | Director of Finance/CFO | 53 | - |
Steven Elms
CHM | Chairman | 60 | 19-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
R. Carruthers
BRD | Director/Board Member | 66 | 21-05-17 |
Timothy Clackson
BRD | Director/Board Member | 58 | 20-04-30 |
Steven Elms
CHM | Chairman | 60 | 19-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 3.53 | -4.08% | 246,148 |
24-06-06 | 3.68 | -1.08% | 259,341 |
24-06-05 | 3.72 | +1.22% | 392,847 |
24-06-04 | 3.675 | -2.78% | 296,249 |
24-06-03 | 3.78 | -5.97% | 564,646 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+557.36% | 193M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- ELEV Stock